Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) EBITDA Margin %: 0.00% (As of . 20)


What is Pharmedic Pharmaceutical Medicinal Joint Stock Company EBITDA Margin %?

Pharmedic Pharmaceutical Medicinal Joint Stock Company HSTC:PMC EBITDA Margin % is 0.00% as of . 20.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Pharmedic Pharmaceutical Medicinal Joint Stock Company's EBITDA for the three months ended in . 20 was ₫0.00 Mil. Pharmedic Pharmaceutical Medicinal Joint Stock Company's Revenue for the three months ended in . 20 was ₫0.00 Mil. Therefore, Pharmedic Pharmaceutical Medicinal Joint Stock Company's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Pharmedic Pharmaceutical Medicinal Joint Stock Company  (HSTC:PMC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Pharmedic Pharmaceutical Medicinal Joint Stock Company EBITDA Margin % Related Terms

Pharmedic Pharmaceutical Medicinal Joint Stock Company EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmedic Pharmaceutical Medicinal Joint Stock Company EBITDA Margin % Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data
Trend
EBITDA Margin %

Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data
EBITDA Margin %

HSTC:PMC vs IMNPQ: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmedic Pharmaceutical Medicinal Joint Stock Company's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmedic Pharmaceutical Medicinal Joint Stock Company EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmedic Pharmaceutical Medicinal Joint Stock Company's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Pharmedic Pharmaceutical Medicinal Joint Stock Company's EBITDA Margin % falls into.


Pharmedic Pharmaceutical Medicinal Joint Stock Company EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Pharmedic Pharmaceutical Medicinal Joint Stock Company's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Pharmedic Pharmaceutical Medicinal Joint Stock Company and its competitors.
Is Pharmedic Pharmaceutical Medicinal Joint Stock Company's EBITDA Margin % too high?
Pharmedic Pharmaceutical Medicinal Joint Stock Company's current EBITDA Margin % is 0.00%.
How does Pharmedic Pharmaceutical Medicinal Joint Stock Company's EBITDA Margin % compare to IMNPQ?
Pharmedic Pharmaceutical Medicinal Joint Stock Company's EBITDA Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.39, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Pharmedic Pharmaceutical Medicinal Joint Stock Company and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmedic Pharmaceutical Medicinal Joint Stock Company's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmedic Pharmaceutical Medicinal Joint Stock Company stock overvalued right now?
Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Business Description

Address 367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM
Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, cosmetics, medical supplies, and other products in the health sector. The company's products include Farzincol Bottle, Farzincol Syrup, Sibemag, Vitamin C 50, Vitamin PP 500, Vitamin PP 50, Nacofar, Cooldrop, Inhaler, Povidine 10% 90ml, Povidine 4% 500, Povidine 10% 8ml, and Povidine 4% 800.